- Rosiglitazone and Atherosclerosis (APPROACH)
- Stem cell therapy
- Statin in primary prevention (JUPITER)
- Antithrombotics in ACS
- Tight glucose control and CV risk
- DES good, bad or ugly
- Statin and cancer: a play of chance?
- Cardiometabolic risk: case presentation
- Hs-CRP and risk stratification
- HDL cholesterol
- Non-HDL cholesterol
- Egyptian risk factor project
- Vascular intervention: case discussion
- From Leptin resistance to Insulin resistance
- Cardiac Steatosis
- Surgery, PCI or drugs
